Yanxian F. Chen

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Differences in Posterior Ocular Morphology Following Red Light Therapy Versus 0.01% Atropine for Myopia Control: A Randomized Controlled Trial Analysis.

Differences in Posterior Ocular Morphology Following Red Light Therapy Versus 0.01% Atropine for Myopia Control: A Randomized Controlled Trial Analysis.

Journal: Investigative ophthalmology & visual science

Published: July 14, 2026

Consensus on Diagnostic Criteria, Clinical Symptoms, and Risk Factors for Visual Fatigue: A Modified Delphi Study.

Consensus on Diagnostic Criteria, Clinical Symptoms, and Risk Factors for Visual Fatigue: A Modified Delphi Study.

Journal: Ophthalmology and therapy

Published: July 02, 2026

Repeated low-level red-light therapy for improving asthenopic symptoms and accommodation in presbyopia.

Repeated low-level red-light therapy for improving asthenopic symptoms and accommodation in presbyopia.

Journal: Annals of medicine

Published: April 28, 2026

Efficacy of red light for myopia control from age 2 to 24 with diverse treatment periods: A real-world study.

Efficacy of red light for myopia control from age 2 to 24 with diverse treatment periods: A real-world study.

Journal: Photodiagnosis and photodynamic therapy

Published: February 23, 2026

Expert Opinion on Myopia Tapering: Strategies for Managing Myopia Progression.

Expert Opinion on Myopia Tapering: Strategies for Managing Myopia Progression.

Journal: Ophthalmic epidemiology

Published: February 18, 2026

Clinical manifestations, prevalence, and risk factors of asthenopia: a systematic review and meta-analysis.

Clinical manifestations, prevalence, and risk factors of asthenopia: a systematic review and meta-analysis.

Journal: Journal of global health

Published: February 06, 2026

Repeated low-level red-light therapy for myopia control: An update on efficacy and safety.

Repeated low-level red-light therapy for myopia control: An update on efficacy and safety.

Journal: Taiwan journal of ophthalmology

Published: November 24, 2025

Six-Month Interim Analyses of the Efficacy of Repeated Low-Level Red-Light Therapy Combined with Orthokeratology for Myopia Control in Spanish Children.

Six-Month Interim Analyses of the Efficacy of Repeated Low-Level Red-Light Therapy Combined with Orthokeratology for Myopia Control in Spanish Children.

Journal: Ophthalmic epidemiology

Published: October 30, 2025

Three-year efficacy and safety of repeated low-level red-light therapy for myopia control: a multicentre real-world study.

Three-year efficacy and safety of repeated low-level red-light therapy for myopia control: a multicentre real-world study.

Journal: The British journal of ophthalmology

Published: September 26, 2025

Identifying Biomarkers Using a Portable, Home-Based Eye-Tracking System to Predict Short-Term Visual Fatigue Deterioration: Prospective Observational Feasibility Study.

Identifying Biomarkers Using a Portable, Home-Based Eye-Tracking System to Predict Short-Term Visual Fatigue Deterioration: Prospective Observational Feasibility Study.

Journal: JMIR human factors

Published: September 20, 2025

The retina-body axis: proteomic mechanisms linking oculomics and clinical traits in a female aging cohort.

The retina-body axis: proteomic mechanisms linking oculomics and clinical traits in a female aging cohort.

Journal: npj aging

Published: September 14, 2025

Repeated low-level red-light therapy combined with orthokeratology for myopia control in Spain: a randomised controlled study.

Repeated low-level red-light therapy combined with orthokeratology for myopia control in Spain: a randomised controlled study.

Journal: The British journal of ophthalmology

Published: August 07, 2025

Showing 1-12 of 44

Last Updated: 09/26/2026